{"id":"W2111884657","doi":"10.1310/hct1306-335","title":"Abacavir/Lamivudine Fixed-Dose Combination With Ritonavir-Boosted Darunavir: A Safe and Efficacious Regimen for HIV Therapy","year":2012,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Abacavir; Darunavir; Emtricitabine; Lamivudine; Regimen; Ritonavir; Internal medicine; Gastroenterology; Viral load; Creatinine; Human immunodeficiency virus (HIV); Antiretroviral therapy; Immunology; Hepatitis B virus; Virus","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002728751,0.0002691474,0.0003208974,0.0002549021,0.0002375789,0.0002707217,0.000311904,0.0002078264,0.002545437],"category_scores_gemma":[0.0002131335,0.00008195105,0.0001931734,0.0001571475,0.0001365033,0.00009823589,0.0001260234,0.0004828483,0.0007754176],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004401988,"about_ca_system_score_gemma":0.0006097154,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002221101,"about_ca_topic_score_gemma":0.006179678,"domain_scores_codex":[0.9998323,0.00004854059,0.00001118817,0.00001687547,0.00006210325,0.00002898555],"domain_scores_gemma":[0.9999341,0.00000547276,0.00002066743,0.000005676433,0.00001048541,0.00002366602],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.004623309,0.002590743,0.02842944,0.0004931383,0.0001984954,0.002336168,0.0001985859,0.0005375996,0.07411403,0.0006252575,0.01135768,0.8744956],"study_design_scores_gemma":[0.02854712,0.06283733,0.556927,0.0007777882,0.0009048618,0.02614827,0.0002362436,0.006872396,0.04144503,0.001242785,0.2739515,0.0001097117],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9114989,0.05704965,0.006949391,0.002940088,0.0004405503,0.001548785,0.0007936529,0.0004621081,0.01831684],"genre_scores_gemma":[0.9755652,0.008741773,0.007955506,0.000847725,0.00042971,0.000251456,0.0005463093,0.00002469728,0.005637537],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002545437,"threshold_uncertainty_score":0.008515358,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1741915860826942,"score_gpt":0.4424751159049179,"score_spread":0.2682835298222236,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}